On July 25, American biotechnology company Windtree Therapeutics (NASDAQ: WINT) announced on July 24 that it has signed a common stock purchase agreement worth up to $500 million to establish an equity line of credit (ELOC) and reached an additional $20 million stock purchase agreement with Build and Build Corp. The company stated that 99% of the proceeds from these two financings will be used for the acquisition of BNB Crypto Assets to strengthen its innovative Crypto Assets funding strategy. Windtree CEO Jed Latkin stated that this move is an important part of the company's strategy to diversify its financial assets, but the use of ELOC requires prior approval from shareholders to increase the authorized shares of common stock. Previously, Windtree announced a strategic partnership with the crypto exchange Kraken to provide services for its BNB custody, trading, and OTC Trading.